Skip to main content
MedicHelpLine
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

CAPTOPRIL AND HYDROCHLOROTHIAZIDE

CAPTOPRIL; HYDROCHLOROTHIAZIDE

Standard Dose
25MG;25MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview CAPTOPRIL AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 075055 (ANDA).

Marketing status: Discontinued Active ingredient CAPTOPRIL; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 25MG;25MG Sponsor IVAX SUB TEVA PHARMS Submission history Latest submission status date: 2002-07-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview CAPTOPRIL AND HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 075055 (ANDA). Marketing status: Discontinued Active ingredient CAPTOPRIL; HYDROCHLOROTHIAZIDE Form and strength TABLET;ORAL - 25MG;25MG Sponsor IVAX SUB TEVA PHARMS Submission history Latest submission status date: 2002-07-29 00:00:00. Submission type: SUPPL.

Monitoring

  • Review priority: STANDARD
  • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.